While a similar bias from screening is likely to occur in colon and breast cancer, the relevant screening tests were introduced very much earlier and are vigorously promoted in the UK, making selective uptake of the tests much less likely than is the case with the PSA. Here, KLK3 is linked to breast carcinoma.